Unknown

Dataset Information

0

Motivational Enhancement System for Adherence (MESA): pilot randomized trial of a brief computer-delivered prevention intervention for youth initiating antiretroviral treatment.


ABSTRACT: To pilot test a two-session computer-delivered motivational intervention to facilitate adherence among youth with HIV newly prescribed antiretroviral treatment (ART).Youth (N = 76) newly prescribed ART were recruited from 8 sites, and were randomized to the intervention or an active nutrition and physical activity control. Primary outcomes were HIV-1 viral load at baseline, 3 months, and 6 months, and self-reported adherence at 3 and 6 months.Satisfaction ratings were high. Effect sizes suggested that the intervention group showed a greater drop than controls in viral load from baseline to 6 months (Cohen's d = 0.39 at 3 months; d = 0.19 at 6 months), and had greater percent undetectable by 6 months (d = 0.28). Effects sizes were medium to large for 7-day and weekend adherence.A brief computer-delivered motivational intervention showed promise for youth starting ART and is ready to be tested in a full-scale clinical trial.

SUBMITTER: Naar-King S 

PROVIDER: S-EPMC3701125 | biostudies-literature | 2013 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Motivational Enhancement System for Adherence (MESA): pilot randomized trial of a brief computer-delivered prevention intervention for youth initiating antiretroviral treatment.

Naar-King Sylvie S   Outlaw Angulique Y AY   Sarr Moussa M   Parsons Jeffrey T JT   Belzer Marvin M   Macdonell Karen K   Tanney Mary M   Ondersma Steven J SJ  

Journal of pediatric psychology 20130128 6


<h4>Objective</h4>To pilot test a two-session computer-delivered motivational intervention to facilitate adherence among youth with HIV newly prescribed antiretroviral treatment (ART).<h4>Methods</h4>Youth (N = 76) newly prescribed ART were recruited from 8 sites, and were randomized to the intervention or an active nutrition and physical activity control. Primary outcomes were HIV-1 viral load at baseline, 3 months, and 6 months, and self-reported adherence at 3 and 6 months.<h4>Results</h4>Sat  ...[more]

Similar Datasets

| S-EPMC6903743 | biostudies-literature
| S-EPMC4980541 | biostudies-literature
| S-EPMC3599639 | biostudies-literature
| S-EPMC8709919 | biostudies-literature
| S-EPMC9641591 | biostudies-literature
| S-EPMC4490994 | biostudies-literature
| S-EPMC3818299 | biostudies-literature
| S-EPMC5035162 | biostudies-literature
| S-EPMC6609091 | biostudies-literature
| S-EPMC8099490 | biostudies-literature